Urotensin II , human CAS NO.251293-28-4

Urotensin II , human CAS NO.251293-28-4

Urotensin II , human CAS NO.251293-28-4

Urotensin II , human CAS NO.251293-28-4

Urotensin II , human CAS NO.251293-28-4

Urotensin II, human is a cyclic 11-amino acid peptide with a disulfide bond between Cys⁵ and Cys¹⁰ and C-terminal amidation, supplied as a lyophilized powder with ≥95% HPLC purity and low endotoxin levels. This research-grade peptide is the endogenous ligand for the urotensin II receptor (UT, GPR14) and is recognized as one of the most potent vasoactive peptides in mammals. It is designed for studies of cardiovascular function, vascular tone regulation, and cardiac remodeling in human-relevant in vitrosystems, serving as a critical tool for investigating the urotensin system's role in hypertension, heart failure, and vascular diseases.



TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
Urotensin II , human
CAS NO.
251293-28-4
Appearance
White to off-white lyophilized powder
Molecular Formula
 C64H85N13O18S2
Molecular Weight
 1388.6g/mol 
Purity (RP-HPLC)
≥ 95.0%
Solubility

Soluble in water, phosphate‑buffered saline (PBS), or dilute acetic acid (e.g., 0.1% v/v). For best results, first dissolve in a small volume of 0.1% acetic acid or sterile water to prepare a 0.1–1.0 mg/mL stock solution.

Endotoxin< 1.0 EU/mg
Biological Activity
Urotensin II is a potent vasoactive cyclic peptide and the most potent known vasoconstrictor. It binds with high affinity to the G‑protein coupled receptor UT (GPR14), primarily coupling to Gq/11 to stimulate phospholipase C, leading to increased intracellular calcium and vasoconstriction. It is also involved in cardiac remodeling, fibrosis, and inflammation. Bioactivity is typically confirmed by vasoconstriction assays in isolated vessels or calcium mobilization assays in UT‑expressing cells.
Storage Conditions
Lyophilized powder: Store desiccated at –20 °C or below, protected from light, for long‑term stability.
Reconstituted solution: Aliquot and store at ≤ –20 °C; avoid repeated freeze‑thaw cycles. For extended stability, store at –80 °C.
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

Urotensin II, human exerts its biological effects by binding with high affinity to the G protein-coupled receptor UT (GPR14), primarily coupling to Gq/11 to activate phospholipase C and increase intracellular calcium mobilization. This signaling cascade leads to potent vasoconstriction in vascular smooth muscle cells and modulates cardiac contractility, fibrosis, and inflammatory responses. The peptide's cyclic structure is essential for receptor recognition and potency, and it exhibits minimal cross-reactivity with other vasoactive peptide receptors, making it a selective tool for studying UT-mediated pathways in cardiovascular physiology and pathology.


2.PRODUCT INDICATIONS

This peptide is indicated for research applications focused on cardiovascular biology, vascular tone regulation, and cardiac remodeling in human-relevant in vitrosystems. It is utilized in in vitroassays with UT-expressing cells to study calcium flux, vasoconstriction, and intracellular signaling pathways. The product also serves as a reference standard for receptor binding studies, autoradiography, and functional assays to investigate the role of the urotensin system in hypertension, pulmonary hypertension, heart failure, and vascular diseases, contributing to the understanding of UT as a therapeutic target.


3.CLINICAL EFFICACY OF PRODUCT

Urotensin II, human has no clinical efficacy or safety profile, as it is strictly a research reagent for preclinical investigations. The peptide has not undergone clinical trials, regulatory evaluation, or safety assessment for diagnostic or therapeutic use in humans. While preclinical studies demonstrate its potent vasoconstrictor and pro-fibrotic effects in cardiovascular models, these findings remain exploratory and have not been translated into validated clinical interventions. Any potential therapeutic applications would require the development of UT antagonists or modulators with comprehensive pharmacokinetic and safety evaluations.


4.DELIVERY & SHIPPING

We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods 
Main Method: International Air Freight

We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

Premium API Oxandrolone Ucinky Manufacturing
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
Clinical Benefits and Applications of Oxandrolone Therapy
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.
Clinical Benefits and Production of Oxandrolone Steroid
May 20, 26
Clinical Benefits and Production of Oxandrolone Steroid
The global pharmaceutical landscape has seen a significant rise in the demand for highly specialized anabolic agents, among which the oxandrolone steroid stands out due to its unique chemical profile and therapeutic versatility. As a modified version of dihydrotestosterone, this compound provides a potent means of addressing muscle wasting and metabolic deficits, making it a critical asset in both clinical rehabilitation and advanced physiological research. Understanding the nuances of this synthetic compound is essential for healthcare providers and researchers alike, as it balances efficacy with a relatively lower androgenic profile compared to other steroids.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.